Transgene SA (EPA:TNG)
France flag France · Delayed Price · Currency is EUR
0.7140
+0.0030 (0.42%)
Aug 3, 2026, 12:42 PM CET

Transgene Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
7.217.216.357.910.3417.41
Revenue Growth
2045.83%13.49%-19.58%-23.63%-40.60%75.62%
Gross Profit
4.587.216.357.910.3417.41
Operating Income
-35.06-35.06-35.66-30.05-29.9-23.53
Net Income
-37.52-37.52-33.97-22.33-32.8-19.54
Earnings Per Share
-0.26-0.26-0.29-0.22-0.33-0.21
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
111.86111.8616.6715.6726.8349.57
Total Debt
2.062.0610.417.313.5216.64
Net Cash (Debt)
109.8109.86.27-1.6313.3132.93
Net Cash Growth
-1650.06%---59.59%312.18%
Net Cash Per Share
0.760.760.05-0.020.130.36

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-37.05-37.05-23.55-34.67-20.3-25.91
Capital Expenditures
-0.84-0.84-3.07-2.67-1.5-0.67
Free Cash Flow
-37.89-37.89-26.61-37.34-21.8-26.58
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
63.51%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-486.25%-486.25%-561.28%-380.34%-289.10%-135.10%
Pretax Margin
-520.44%-520.44%-534.72%-282.63%-317.13%-112.19%
Profit Margin
-520.44%-520.44%-534.72%-282.63%-317.13%-112.19%
FCF Margin
-525.49%-525.49%-418.92%-472.63%-210.75%-152.65%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-10.0410.0410.0410.0410.04
PS Ratio
27.0136.5114.1617.4916.0614.26